ACADIA Pharmaceuticals Inc.

Healthcare

NASDAQ:ACAD · NASDAQ Global Select

Market Cap $3.70B Beta 0.83 P/E (TTM) 9.7

$21.62 -0.60%

-$0.13 today

52W Low $19.69High $28.35

Vol 3.23M · Avg 1.66M

EPS (TTM) $2.20Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-3.83%

Period High

$28.06

Period Low

$20.06

Latest

$21.62

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Immunovant, Inc.

NASDAQ:IMVT

$7.19B

Praxis Precision Medicines, Inc.

NASDAQ:PRAX

$5.90B

Belite Bio, Inc

NASDAQ:BLTE

$5.88B

Ligand Pharmaceuticals Incorporated

NASDAQ:LGND

$5.37B

Mirum Pharmaceuticals, Inc.

NASDAQ:MIRM

$5.27B

Crinetics Pharmaceuticals, Inc.

NASDAQ:CRNX

$3.75B

Viking Therapeutics, Inc.

NASDAQ:VKTX

$3.56B

Dyne Therapeutics, Inc.

NASDAQ:DYN

$3.25B

Soleno Therapeutics, Inc.

SLNO

$2.76B

ADMA Biologics, Inc.

NASDAQ:ADMA

$1.96B

What is the latest ACAD filing?

The latest filing shown is S-8 dated Jun 10, 2026.

How many recent filings does ACAD have?

Intrinsic Alpha currently shows 20 recent filings for ACAD.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.